Zenghong Huang

RORγ is a targetable master regulator of cholesterol biosynthesis in a cancer subtype

Demin Cai, Junjian Wang, Bei Gao et al. · Nature Communications · 2019 · 166 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Epigenetic silencing of TPM2 contributes to colorectal cancer progression upon RhoA activation

Ji Cui, Yonghua Cai, Ying Hu et al. · Tumor Biology · 2016 · 46 citations

Medicine, Molecular Biology, Oncology +17

Prognostic value of preoperative carcinoembryonic antigen/tumor size in rectal cancer

Du Cai, Zenghong Huang, Huichuan Yu et al. · World Journal of Gastroenterology · 2019 · 39 citations · Full text

Medicine, Oncology, Surgery +17

Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer

Yan Zhang, Xishan Wu, Xiaoqian Xue et al. · Journal of Medicinal Chemistry · 2019 · 38 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Therapeutic Targeting of MDR1 Expression by RORγ Antagonists Resensitizes Cross-Resistant CRPC to Taxane via Coordinated Induction of Cell Death Programs

Yongqiang Wang, Zenghong Huang, Christopher Z. Chen et al. · Molecular Cancer Therapeutics · 2019 · 31 citations

Medicine, Oncology, Pharmacology +16